Overview

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

Study to evaluate the safety, tolerability and pharmacokinetics of multiple escalating doses of intravenous WCK 5222 (Zidebactam and Cefepime) in healthy adult human subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Wockhardt

Collaborator:

Quintiles, Inc.

Treatments:

Cefepime